264 related articles for article (PubMed ID: 25145553)
1. Controversies in multiple myeloma: to transplant or not?
Preeshagul IR; Van Besien K; Mark TM
Curr Hematol Malig Rep; 2014 Dec; 9(4):360-7. PubMed ID: 25145553
[TBL] [Abstract][Full Text] [Related]
2. Stem Cell Transplantation in Multiple Myeloma.
Offidani M; Gentili S; Gay F; Aghemo E; Maracci L; Corvatta L; Palumbo A
Curr Cancer Drug Targets; 2017; 17(9):769-781. PubMed ID: 27659429
[TBL] [Abstract][Full Text] [Related]
3. Augmenting Autologous Stem Cell Transplantation to Improve Outcomes in Myeloma.
Maybury B; Cook G; Pratt G; Yong K; Ramasamy K
Biol Blood Marrow Transplant; 2016 Nov; 22(11):1926-1937. PubMed ID: 27288955
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.
Martino M; Morabito F
Expert Opin Biol Ther; 2015 Feb; 15(2):149-54. PubMed ID: 25435056
[TBL] [Abstract][Full Text] [Related]
5. Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis.
Lin CM; Chang LC; Shau WY; Chen CL; Yao CY; Tien FM
BMC Cancer; 2023 May; 23(1):446. PubMed ID: 37193978
[TBL] [Abstract][Full Text] [Related]
6. The role of pre-transplant induction regimens and autologous stem cell transplantation in the era of novel targeted agents.
Gay F; Cavallo F; Palumbo A
Drugs; 2015 Mar; 75(4):367-75. PubMed ID: 25764394
[TBL] [Abstract][Full Text] [Related]
7. Optimizing therapy for transplant-eligible patients with newly diagnosed multiple myeloma.
Moreau P; Giralt SA
Leuk Res; 2012 Nov; 36 Suppl 1():S13-8. PubMed ID: 23176719
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
Malard F; Harousseau JL; Mohty M
Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
[TBL] [Abstract][Full Text] [Related]
9. Role of consolidation therapy in transplant eligible multiple myeloma patients.
Cavo M; Brioli A; Tacchetti P; Zannetti BA; Mancuso K; Zamagni E
Semin Oncol; 2013 Oct; 40(5):610-7. PubMed ID: 24135406
[TBL] [Abstract][Full Text] [Related]
10. Evolving therapeutic paradigms for multiple myeloma: back to the future.
Cherry BM; Korde N; Kwok M; Roschewski M; Landgren O
Leuk Lymphoma; 2013 Mar; 54(3):451-63. PubMed ID: 22880935
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients.
Fassas AB; Spencer T; Desikan R; Zangari M; Anaissie E; Barlogie B; Tricot G
Br J Haematol; 2002 Oct; 119(1):164-8. PubMed ID: 12358921
[TBL] [Abstract][Full Text] [Related]
12. Treatment of transplant-eligible patients with multiple myeloma in 2014.
Landau H; Giralt S
Hematol Oncol Clin North Am; 2014 Oct; 28(5):815-27. PubMed ID: 25212884
[TBL] [Abstract][Full Text] [Related]
13. Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
Yip HM; Yong K; De-Silva D; Rabin N
Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):160-162. PubMed ID: 32192978
[TBL] [Abstract][Full Text] [Related]
14. Have drug combinations supplanted stem cell transplantation in myeloma?
Palumbo A; Cavallo F
Hematology Am Soc Hematol Educ Program; 2012; 2012():335-41. PubMed ID: 23233601
[TBL] [Abstract][Full Text] [Related]
15. Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.
Mina R; Petrucci MT; Corradini P; Spada S; Patriarca F; Cerrato C; De Paoli L; Pescosta N; Ria R; Malfitano A; Musto P; Baldini L; Guglielmelli T; Gamberi B; Mannina D; Benevolo G; Zambello R; Falcone AP; Palumbo A; Nagler A; Calafiore V; Hájek R; Spencer A; Boccadoro M; Bringhen S
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):533-540. PubMed ID: 29910180
[TBL] [Abstract][Full Text] [Related]
16. ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Offidani M; Leoni P; Corvatta L; Polloni C; Gentili S; Savini A; Alesiani F; Brunori M; Catarini M; Visani G; Samori A; Burattini M; Centurioni R; Montanari M; Fraticelli P; Ruggieri M; Falcioni S; Galieni P
Eur J Haematol; 2010 Jun; 84(6):474-83. PubMed ID: 20331733
[TBL] [Abstract][Full Text] [Related]
17. Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents.
Merz M; Neben K; Raab MS; Sauer S; Egerer G; Hundemer M; Hose D; Kunz C; Heiß C; Ho AD; Goldschmidt H; Hillengass J
Ann Oncol; 2014 Jan; 25(1):189-95. PubMed ID: 24356629
[TBL] [Abstract][Full Text] [Related]
18. The future of autologous stem cell transplantation in myeloma.
van Rhee F; Giralt S; Barlogie B
Blood; 2014 Jul; 124(3):328-33. PubMed ID: 24894774
[TBL] [Abstract][Full Text] [Related]
19. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.
Cavo M; Rajkumar SV; Palumbo A; Moreau P; Orlowski R; Bladé J; Sezer O; Ludwig H; Dimopoulos MA; Attal M; Sonneveld P; Boccadoro M; Anderson KC; Richardson PG; Bensinger W; Johnsen HE; Kroeger N; Gahrton G; Bergsagel PL; Vesole DH; Einsele H; Jagannath S; Niesvizky R; Durie BG; San Miguel J; Lonial S;
Blood; 2011 Jun; 117(23):6063-73. PubMed ID: 21447828
[TBL] [Abstract][Full Text] [Related]
20. Treatment for patients with newly diagnosed multiple myeloma in 2015.
Mateos MV; Ocio EM; Paiva B; Rosiñol L; Martínez-López J; Bladé J; Lahuerta JJ; García-Sanz R; San Miguel JF
Blood Rev; 2015 Nov; 29(6):387-403. PubMed ID: 26094881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
